Editor’s Special Episode: Innovations in B-NHL
Tycel Phillips, MDAggressive B-Cell Lymphoma | July 18, 2025

Tycel Phillips, MD, discusses the evolving treatment landscape for B-cell non-Hodgkin lymphoma, from BTK inhibitors in mantle cell lymphoma to BCL6 degraders in follicular lymphoma.

Advertisement
Advertisement

Advertisement
Advertisement
Editorial Board

Podcasts

Alexey V. Danilov, MD, PhDChronic Lymphocytic Leukemia | July 16, 2025
Dr. Alexey Danilov discusses new therapies and ongoing challenges in the evolving CLL treatment landscape.
Saad Z. Usmani, MD, MBA, FACPMyeloma | July 3, 2025
Experts discuss quadruplet therapy, MRD, and evolving transplant decisions in newly diagnosed multiple myeloma.
Nichole TuckerAcute Myeloid Leukemia | June 30, 2025
Dr. Amir Fathi discusses oral regimens and future AML therapy trends in this Editor’s Special of The HemOnc Pulse.
Rahul Banerjee, MD, FACPThe HemOnc Pulse | June 30, 2025
Can tech bridge the cancer care gap? Dr. Banerjee and Dr. Longmire explore solutions for drug accessibility.
Rahul Banerjee, MD, FACPAggressive B-Cell Lymphoma | June 30, 2025
Experts explore CAR T therapy challenges and the future of lymphoma care beyond CD19-targeted treatments.
Rahul Banerjee, MD, FACPAcute Myeloid Leukemia | June 30, 2025
Experts discuss early detection in myeloid malignancies, from current challenges to future innovations.
Rahul Banerjee, MD, FACPMyelodysplastic Syndromes | June 5, 2025
At The HemOnc Pulse Live!, experts debate key controversies in MDS care, from frontline therapy to emerging treatments.
Rahul Banerjee, MD, FACPMyeloma | May 5, 2025
Gurbakhash Kaur, MD joins the host of The HemOnc Pulse Live! for a comprehensive discussion about the RedirecT-1 trial.

Trending on MashupMD